 |
PDBsum entry 2imm
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immunoglobulin
|
PDB id
|
|
|
|
2imm
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Mol Biol
225:739-753
(1992)
|
|
PubMed id:
|
|
|
|
|
| |
|
Refined crystal structure of a recombinant immunoglobulin domain and a complementarity-determining region 1-grafted mutant.
|
|
B.Steipe,
A.Plückthun,
R.Huber.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We report the solution of the crystal structure of a mutant of the
immunoglobulin VL domain of the antibody McPC603, in which the
complementarity-determining region 1 segment is replaced with that of a
different antibody. The wild-type and mutant crystal structures have been
refined to a crystallographic R-factor of 14.9% at a nominal resolution of 1.97
A. A detailed description of the structures is given. Crystal packing results in
a dimeric association of domains, in a fashion closely resembling that of an Fv
fragment. The comparison of this VL domain with the same domain in the Fab
fragment of McPC603 shows that the structure of an immunoglobulin VL domain is
largely independent of its mode of association, even in places where the
inter-subunit contacts are not conserved between VL and VH. In all three
complementarity-determining regions we observe conformations that would not have
been predicted by the canonical structure hypothesis. Significant differences
between the VL domain dimer and the Fab fragment in the third
complementarity-determining region show that knowledge of the structure of the
dimerization partner and its exact mode of association may be needed to predict
the precise conformation of antigen-binding loops.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.N.Falco,
K.M.Dykstra,
B.P.Yates,
and
P.B.Berget
(2009).
scFv-based fluorogen activating proteins and variable domain inhibitors as fluorescent biosensor platforms.
|
| |
Biotechnol J,
4,
1328-1336.
|
 |
|
|
|
|
 |
C.Breithaupt,
A.Schubart,
H.Zander,
A.Skerra,
R.Huber,
C.Linington,
and
U.Jacob
(2003).
Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein.
|
| |
Proc Natl Acad Sci U S A,
100,
9446-9451.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.O.Essen,
A.Harrenga,
C.Ostermeier,
and
H.Michel
(2003).
1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.
|
| |
Acta Crystallogr D Biol Crystallogr,
59,
677-687.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.R.Pokkuluri,
M.Gu,
X.Cai,
R.Raffen,
F.J.Stevens,
and
M.Schiffer
(2002).
Factors contributing to decreased protein stability when aspartic acid residues are in beta-sheet regions.
|
| |
Protein Sci,
11,
1687-1694.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.R.Pokkuluri,
R.Raffen,
L.Dieckman,
C.Boogaard,
F.J.Stevens,
and
M.Schiffer
(2002).
Increasing protein stability by polar surface residues: domain-wide consequences of interactions within a loop.
|
| |
Biophys J,
82,
391-398.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Jäger,
and
A.Plückthun
(2000).
Direct evidence by H/D exchange and ESI-MS for transient unproductive domain interaction in the refolding of an antibody scFv fragment.
|
| |
Protein Sci,
9,
552-563.
|
 |
|
|
|
|
 |
P.R.Pokkuluri,
X.Cai,
G.Johnson,
F.J.Stevens,
and
M.Schiffer
(2000).
Change in dimerization mode by removal of a single unsatisfied polar residue located at the interface.
|
| |
Protein Sci,
9,
1852-1855.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.R.Pokkuluri,
D.B.Huang,
R.Raffen,
X.Cai,
G.Johnson,
P.W.Stevens,
F.J.Stevens,
and
M.Schiffer
(1998).
A domain flip as a result of a single amino-acid substitution.
|
| |
Structure,
6,
1067-1073.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.C.Ohage,
W.Graml,
M.M.Walter,
S.Steinbacher,
and
B.Steipe
(1997).
Beta-turn propensities as paradigms for the analysis of structural motifs to engineer protein stability.
|
| |
Protein Sci,
6,
233-241.
|
 |
|
|
|
|
 |
X.Y.Pei,
P.Holliger,
A.G.Murzin,
and
R.L.Williams
(1997).
The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3.
|
| |
Proc Natl Acad Sci U S A,
94,
9637-9642.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.E.Bruggeman,
A.Honegger,
H.Kreuwel,
A.J.Visser,
C.Laane,
A.Schots,
and
R.Hilhorst
(1997).
Regulation of the flavin redox potential by flavin-binding antibodies.
|
| |
Eur J Biochem,
249,
393-400.
|
 |
|
|
|
|
 |
D.Plaksin,
S.Chacko,
P.McPhie,
A.Bax,
E.A.Padlan,
and
D.H.Margulies
(1996).
A T cell receptor V alpha domain expressed in bacteria: does it dimerize in solution?
|
| |
J Exp Med,
184,
1251-1258.
|
 |
|
|
|
|
 |
S.Spinelli,
L.Frenken,
D.Bourgeois,
L.de Ron,
W.Bos,
T.Verrips,
C.Anguille,
C.Cambillau,
and
M.Tegoni
(1996).
The crystal structure of a llama heavy chain variable domain.
|
| |
Nat Struct Biol,
3,
752-757.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.M.Tomlinson,
J.P.Cox,
E.Gherardi,
A.M.Lesk,
and
C.Chothia
(1995).
The structural repertoire of the human V kappa domain.
|
| |
EMBO J,
14,
4628-4638.
|
 |
|
|
|
|
 |
A.R.Rees,
D.Staunton,
D.M.Webster,
S.J.Searle,
A.H.Henry,
and
J.T.Pedersen
(1994).
Antibody design: beyond the natural limits.
|
| |
Trends Biotechnol,
12,
199-206.
|
 |
|
|
|
|
 |
D.M.Webster,
J.Pedersen,
D.Staunton,
A.Jones,
and
A.R.Rees
(1994).
Antibody-combining sites. Extending the natural limits.
|
| |
Appl Biochem Biotechnol,
47,
119.
|
 |
|
|
|
|
 |
R.L.Malby,
W.R.Tulip,
V.R.Harley,
J.L.McKimm-Breschkin,
W.G.Laver,
R.G.Webster,
and
P.M.Colman
(1994).
The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody.
|
| |
Structure,
2,
733-746.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.L.Stanfield,
and
I.A.Wilson
(1994).
Antigen-induced conformational changes in antibodies: a problem for structural prediction and design.
|
| |
Trends Biotechnol,
12,
275-279.
|
 |
|
|
|
|
 |
A.B.Edmundson,
D.L.Harris,
Z.C.Fan,
L.W.Guddat,
B.T.Schley,
B.L.Hanson,
G.Tribbick,
and
H.M.Geysen
(1993).
Principles and pitfalls in designing site-directed peptide ligands.
|
| |
Proteins,
16,
246-267.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Skerra
(1993).
Bacterial expression of immunoglobulin fragments.
|
| |
Curr Opin Immunol,
5,
256-262.
|
 |
|
|
|
|
 |
A.Plückthun
(1992).
Mono- and bivalent antibody fragments produced in Escherichia coli: engineering, folding and antigen binding.
|
| |
Immunol Rev,
130,
151-188.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |